Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis

Liver biopsy is the current reliable way of evaluating liver fibrosis. However, no specific sera biomarker could be applied in clinical diagnosis. As the pivotal role of osteopontin (OPN) reported in numerous liver diseases, thrombin‐cleaved OPN (Thr‐OPN) exposes an integrin‐binding motif that promoted biological functions. Herein, we investigated the potential of Thr‐OPN in liver fibrosis. Using patient samples, mouse models and hepatic stellate cells (HSCs), we analyzed the involvement of Thr‐OPN in liver fibrosis. The result showed that, first, Thr‐OPN level was significantly higher in patients with liver cirrhosis than that in patients with chronic hepatitis B and healthy controls. Thr‐OPN level was positively correlated with liver fibrosis degree in clinical samples. Then in mouse models, it showed a similar correlation between hepatic Thr‐OPN levels and liver fibrosis degree. Thr‐OPN peptides exacerbated liver fibrosis in OPN‐deficient mice, whereas the neutralization of Thr‐OPN alleviated liver fibrosis in wild‐type mice. Furthermore, when compared with full‐length OPN (FL‐OPN), Thr‐OPN exhibited a greater ability to promote HSC activation, proliferation, and migration via mitogen‐activated protein (MAP) kinase and nuclear factor (NF)‐κB pathways. In conclusion, Thr‐OPN, not FL‐OPN, was critically involved in the exacerbation of liver fibrosis by α9 and α4 integrins via MAP kinase and NF‐κB signaling pathway, thus representing a novel diagnostic biomarker and treatment target for liver cirrhosis.

[1]  A. Uchinaka,et al.  SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis , 2015, Molecular and Cellular Biochemistry.

[2]  Lanjuan Li,et al.  Osteopontin promotes dendritic cell maturation and function in response to HBV antigens , 2015, Drug design, development and therapy.

[3]  L. Cui,et al.  Apigenin promotes osteogenic differentiation of human mesenchymal stem cells through JNK and p38 MAPK pathways , 2015, Molecular and Cellular Biochemistry.

[4]  T. Arisawa,et al.  Serum Osteopontin Predicts Degree of Hepatic Fibrosis and Serves as a Biomarker in Patients with Hepatitis C Virus Infection , 2015, PloS one.

[5]  Wenxin Qin,et al.  Diagnostic values of alpha-fetoprotein, dickkopf-1, and osteopontin for hepatocellular carcinoma , 2015, Medical Oncology.

[6]  H. Hagberg,et al.  The effect of osteopontin and osteopontin-derived peptides on preterm brain injury , 2014, Journal of Neuroinflammation.

[7]  Xueping Yu,et al.  Ratios of regulatory T cells/T‐helper 17 cells and transforming growth factor‐β1/interleukin‐17 to be associated with the development of hepatitis B virus‐associated liver cirrhosis , 2014, Journal of gastroenterology and hepatology.

[8]  J. Fallowfield,et al.  Liver fibrosis and repair: immune regulation of wound healing in a solid organ , 2014, Nature Reviews Immunology.

[9]  R. Bataller,et al.  Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis , 2013, Hepatology.

[10]  D. Stainier,et al.  Hepatic stellate cells in liver development, regeneration, and cancer. , 2013, The Journal of clinical investigation.

[11]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[12]  M. Merchant,et al.  Thrombin-cleaved Fragments of Osteopontin Are Overexpressed in Malignant Glial Tumors and Provide a Molecular Niche with Survival Advantage* , 2012, The Journal of Biological Chemistry.

[13]  Lanjuan Li,et al.  Osteopontin regulates interleukin-17 production in hepatitis. , 2012, Cytokine.

[14]  R. Schwabe,et al.  Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. , 2012, Gastroenterology.

[15]  D. Fan,et al.  Osteopontin Contributes to TGF-β1 Mediated Hepatic Stellate Cell Activation , 2012, Digestive Diseases and Sciences.

[16]  N. Kamal,et al.  Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major. , 2012, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

[17]  R. Urtasun,et al.  Osteopontin, an oxidant stress sensitive cytokine, up‐regulates collagen‐I via integrin αVβ3 engagement and PI3K/pAkt/NFκB signaling , 2012, Hepatology.

[18]  J. Ladero.  Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C , 2011, Hepatitis monthly.

[19]  H. Tsukamoto,et al.  Epigenetic cell fate regulation of hepatic stellate cells , 2011, Hepatology research : the official journal of the Japan Society of Hepatology.

[20]  T. Uede.  Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases , 2011, Pathology international.

[21]  G. Karaca,et al.  Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis , 2011, Hepatology.

[22]  H. Okada,et al.  Procarboxypeptidase R deficiency causes increased lethality in concanavalin A-induced hepatitis in female mice. , 2010, Biological & pharmaceutical bulletin.

[23]  M. Maeda,et al.  Thrombin-cleaved Osteopontin Is Increased in Urine of Patients with Rheumatoid Arthritis , 2010, The Journal of Rheumatology.

[24]  Cheang Ly Be,et al.  Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. , 2009, Blood.

[25]  Lanjuan Li,et al.  Osteopontin regulates development and function of invariant natural killer T cells , 2008, Proceedings of the National Academy of Sciences.

[26]  J. Wang,et al.  Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection , 2007, International journal of clinical practice.

[27]  M. Maeda,et al.  Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. , 2004, Immunity.

[28]  W. Hsueh,et al.  Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. , 2003, The Journal of clinical investigation.

[29]  N. Yamamoto,et al.  Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. , 2003, The Journal of clinical investigation.

[30]  Y. Matsui,et al.  Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[31]  L. Steinman,et al.  Transcriptional analysis of targets in multiple sclerosis , 2003, Nature Reviews Immunology.

[32]  Y. Saeki,et al.  Enhanced local production of osteopontin in rheumatoid joints. , 2002, The Journal of rheumatology.

[33]  V. Paradis,et al.  Effects and Regulation of Connective Tissue Growth Factor on Hepatic Stellate Cells , 2002, Laboratory Investigation.

[34]  M. Noda,et al.  Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Jorge R. Oksenberg,et al.  The Influence of the Proinflammatory Cytokine, Osteopontin, on Autoimmune Demyelinating Disease , 2001, Science.

[36]  S. Barry,et al.  Structural elements of the osteopontin SVVYGLR motif important for the interaction with α4 integrins , 2001, FEBS letters.

[37]  C. Giachelli,et al.  Structural Requirements for α9β1-Mediated Adhesion and Migration to Thrombin-Cleaved Osteopontin , 1998 .

[38]  D. Sheppard,et al.  Osteopontin N-terminal Domain Contains a Cryptic Adhesive Sequence Recognized by α9β1 Integrin* , 1996, The Journal of Biological Chemistry.

[39]  L. Brown,et al.  Osteopontin at the Tumor/Host Interface , 1995, Annals of the New York Academy of Sciences.

[40]  H. Kawasaki,et al.  Serum type III procollagen peptide, type IV collagen 7S domain, central triple‐helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology , 1994, Hepatology.

[41]  S. Friedman,et al.  Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Friedman.  Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. , 2008, Physiological reviews.

[43]  A. Chambers,et al.  Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences , 2002, Journal of cellular biochemistry.

[44]  L. Smith,et al.  Structural requirements for alpha 9 beta 1-mediated adhesion and migration to thrombin-cleaved osteopontin. , 1998, Experimental cell research.

[45]  J. Chen,et al.  Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. , 1996, The Journal of biological chemistry.